Somatic cell engineering and the immunotherapy of leukemias and lymphomas
Adv Pharmacol
.
2004:51:347-70.
doi: 10.1016/S1054-3589(04)51015-3.
Authors
Renier J Brentjens
1
,
Michel Sadelain
Affiliation
1
Department of Medicine and Clinical Laboratories, Leukemia Service Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA.
PMID:
15464917
DOI:
10.1016/S1054-3589(04)51015-3
No abstract available
Publication types
Review
MeSH terms
Cancer Vaccines / immunology
Cell- and Tissue-Based Therapy / methods*
Humans
Immunotherapy / methods*
Immunotherapy, Adoptive
Leukemia / immunology*
Leukemia / therapy*
Lymphoma / immunology*
Lymphoma / therapy*
Substances
Cancer Vaccines
Grants and funding
P30 CA008748/CA/NCI NIH HHS/United States